Publications by authors named "S Summermatter"

Article Synopsis
  • - Multiple sclerosis (MS) is an autoimmune disease causing inflammation and damage in the central nervous system, leading to symptoms like muscle dysfunction that can affect mobility and quality of life.
  • - Current treatments mainly focus on neuroinflammation, leaving a need for therapies targeting muscle function, as many people with MS experience skeletal muscle issues that can precede mobility-related disabilities.
  • - Exercise, particularly aerobic and resistance training, is highlighted as an effective intervention to improve muscle strength, reduce fatigue, and enhance overall well-being in individuals with MS, emphasizing the importance of implementing these exercises early on.
View Article and Find Full Text PDF
Article Synopsis
  • Musculoskeletal diseases are a major cause of mobility issues, often linked to muscle weakness, making resistance training a common treatment to boost strength.
  • This study examines the chemerin pathway's role in inflammation and muscle function, finding that blocking a specific receptor (CMKLR1) can temporarily enhance strength but reduces endurance in mice.
  • The research highlights the importance of CMKLR1 in muscle regeneration and contractility, suggesting potential for new drugs targeting this pathway to treat musculoskeletal and other diseases.
View Article and Find Full Text PDF
Article Synopsis
  • Age-related loss of motor neurons affects muscle function, but the exact cause is still not well understood.
  • Research on mice shows that neurotoxic microglia in the spinal cord play a role in this decline, as changes in motor units occur before muscle function decreases.
  • Voluntary exercise and depleting harmful microglia can prevent or reverse this decline, suggesting that targeting these microglia might help maintain muscle health in aging.
View Article and Find Full Text PDF
Article Synopsis
  • * Researchers created specific inhibitors targeting HDAC4 and uncovered three new proteins it modifies: myosin heavy chain, PGC-1α, and Hsc70, which play roles in muscle structure and metabolism.
  • * Blocking HDAC4 can prevent muscle degradation and enhance metabolic pathways, hinting at potential new treatments for muscle disorders and other related diseases.
View Article and Find Full Text PDF
Article Synopsis
  • Advanced cancer patients commonly experience cachexia, a condition that leads to significant muscle loss and affects their treatment response, quality of life, and survival chances.
  • There are currently no effective treatments for cachexia, highlighting the urgent need for early detection and monitoring of muscle mass loss to implement timely interventions.
  • The study introduces simpler experimental cancer models using mice and human cancer cells, allowing for easier observation of muscle deterioration and evaluation of potential therapies for cachexia.
View Article and Find Full Text PDF